Incidence, risk factors for and prognostic role of thromboembolic events (tees) amongst patients with metastatic pancreatic adenocarcinoma (paad): a retrospective, single-center analysis

HIGHLIGHTS

• What: The authors excluded 98 patients for the following reasons: diagnosis of metastatic disease before 1st January 2016 or after 31st December 2021 (34 patients), concomitant primary tumours (26 patients), nommetastatic disease (18 patients), diagnosis of non-pancreatic peri-ampullary tumour (7 patients), treatment outside A.C. Camargo Cancer Center (5 patients) and other reasons (8 patients). The authors show that nearly one in three patients with metastatic PAAD will develop TEEs either at diagnosis or thereafter. The study shows similar findings, with 1.5% of patients dying as a direct consequence of TEE. The authors show . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.